SBFM
Sunshine Biopharma, Inc. (SBFM) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (F). The rating has held at C for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | B (3.5) | C (2.2) | C+ (2.6) | F (0.3) | C+ (2.6) | C (2.2) |
| 2026-11-07 | B+ (3.5) | C (2.2) | C+ (2.6) | F (0.3) | C+ (2.7) | C (2.3) |
| 2026-10-31 | B (3.5) | C (2.2) | C+ (2.7) | F (0.3) | C+ (2.7) | C (2.3) |
| 2026-10-24 | B (3.5) | C (2.2) | C+ (2.7) | F (0.3) | C+ (2.6) | C (2.2) |
| 2026-10-17 | B (3.4) | C (2.2) | C+ (2.7) | F (0.3) | C+ (2.6) | C (2.3) |